FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Percussionaire Recalls Breathing Circuit Kits

[ Price : $8.95]

Percussionaire recalls its High Frequency Transport Phasitron Breathing Circuit Kits due to a product defect that causes over-pres...

Valneva Sells FDA Voucher for $103 Million

[ Price : $8.95]

Valneva says it has sold an FDA tropical disease priority review voucher for $103 million that it will use to fund research and de...

Boston Scientifics Spinal Cord Stimulator Wins 50% Pain Cut OK

[ Price : $8.95]

FDA approves a 50% pain reduction indication for Boston Scientifics WaveWriter Spinal Cord Stimulator in treating chronic low back...

Guide on Reporting Drug Making Amounts

[ Price : $8.95]

Federal Register notice: FDA makes available a final guidance entitled Reporting Amount of Listed Drugs and Biological Products Un...

FDA Again Cites Catalent Facility

[ Price : $8.95]

Bloomberg News reports that FDA inspectors found problems at a Catalent Indiana facility that is being bought by Novo Nordisk to e...

Study on Enhancing Weight-Loss Drugs

[ Price : $8.95]

FDA approves a Veru IND to begin a Phase 2b clinical study to evaluate enobosarm and its use in preserving muscle mass and physica...

Centera, CEO Sentenced Over Unapproved Drugs

[ Price : $8.95]

A federal court sentences Arizona-based Centera Bioscience and CEO Paul Eftang for distributing unapproved drugs into interstate c...

J&J Reports Positive Data on Nipocalimab

[ Price : $8.95]

Johnson & Johnson reports positive data from two studies involving its monoclonal antibody nipocalimab, supporting the drugs poten...

Guidance on Reporting Listed Drug Amounts

[ Price : $8.95]

FDA posts a final guidance entitled Reporting Amount of Listed Drugs and Biological Products Under Section 510(j)(3) of the FD&C A...

Ainos Responds to Clinical Hold on Covid Therapy

[ Price : $8.95]

Ainos files a clinical hold response seeking to begin a Phase 2 trial of its low-dose oral interferon (IFN)-alpha formulation Veld...